首页> 外文期刊>Human Genetics >Mutations of the SLIT2-ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and urinary tract
【24h】

Mutations of the SLIT2-ROBO2 pathway genes SLIT2 and SRGAP1 confer risk for congenital anomalies of the kidney and urinary tract

机译:SLIT2-ROBO2途径基因SLIT2和SRGAP1的突变赋予先天性肾脏和泌尿道异常的风险

获取原文
获取原文并翻译 | 示例
       

摘要

Congenital anomalies of the kidney and urinary tract (CAKUT) account for 40-50 % of chronic kidney disease that manifests in the first two decades of life. Thus far, 31 monogenic causes of isolated CAKUT have been described, explaining similar to 12 % of cases. To identify additional CAKUT-causing genes, we performed whole-exome sequencing followed by a genetic burden analysis in 26 genetically unsolved families with CAKUT. We identified two heterozygous mutations in SRGAP1 in 2 unrelated families. SRGAP1 is a small GTPase-activating protein in the SLIT2-ROBO2 signaling pathway, which is essential for development of the metanephric kidney. We then examined the pathway-derived candidate gene SLIT2 for mutations in cohort of 749 individuals with CAKUT and we identified 3 unrelated individuals with heterozygous mutations. The clinical phenotypes of individuals with mutations in SLIT2 or SRGAP1 were cystic dysplastic kidneys, unilateral renal agenesis, and duplicated collecting system. We show that SRGAP1 is expressed in early mouse nephrogenic mesenchyme and that it is coexpressed with ROBO2 in SIX2-positive nephron progenitor cells of the cap mesenchyme in developing rat kidney. We demonstrate that the newly identified mutations in SRGAP1 lead to an augmented inhibition of RAC1 in cultured human embryonic kidney cells and that the SLIT2 mutations compromise the ability of the SLIT2 ligand to inhibit cell migration. Thus, we report on two novel candidate genes for causing monogenic isolated CAKUT in humans.
机译:肾脏和泌尿系统的先天性异常(CAKUT)占慢性肾病的40-50%,这种病在生命的前二十年中表现出来。到目前为止,已经描述了31种导致分离出的CAKUT的单基因原因,解释了与12%的病例相似的情况。为了确定其他引起CAKUT的基因,我们在26个遗传未解决的CAKUT家庭中进行了全外显子组测序,然后进行了遗传负担分析。我们在两个不相关的家族中鉴定出SRGAP1中的两个杂合突变。 SRGAP1是SLIT2-ROBO2信号传导途径中的一个小GTPase激活蛋白,对于后肾的发育至关重要。然后,我们检查了749位具有CAKUT的患者队列中突变的候选基因SLIT2,并鉴定了3个杂合突变的无关个体。 SLIT2或SRGAP1突变的个体的临床表型为囊性增生性肾脏,单侧肾发育不全和重复收集系统。我们显示SRGAP1在早期小鼠肾原性间充质中表达,它与ROBO2在发育中的大鼠肾脏的帽间质的SIX2阳性肾祖细胞中共表达。我们证明,在SRGAP1中新发现的突变导致在培养的人类胚胎肾细胞中RAC1的抑制作用增强,并且SLIT2突变损害了SLIT2配体抑制细胞迁移的能力。因此,我们报告了两个新的候选基因,用于在人类中引起单基因分离的CAKUT。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号